YCS22· AISerinus Biosciences
Combinations therapy by rational design
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Adjacent
Overlapping tags, a different niche.
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeutics, oncologyActive
Guardian BioS22Dendritic cell-based platform for cancer therapyShared: biotech, therapeutics, oncologyActive
Kopra BioS24Genetically engineered viruses that teach your immune system to kill…Shared: biotech, therapeutics, oncologyActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, oncologyActive
SynsoryBioW24"If-then" conditional logic for protein drugsShared: biotech, therapeutics, oncologyActive
Also from S22 in AI
Batchmates in Summer 2022.
Birch BiosciencesS22We recycle plastic using engineered enzymesActive
KeylikaS22Redefining the Standard of Care for Iron Deficiency AnemiaActive
LaminS22Open data platform for traceable, multimodal AIActive
QuinnS22Your biopharma team, from molecule design to portfolio strategyActive
100xS22Create, Share, and Monetize AI AgentsActive
ActivepiecesS22Open-source, AI-first and no-code business automation toolActive
About Serinus Biosciences
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.
New York City, NY, USA; New York, NY, USA
Serinus Biosciences: questions
Which YC batch was Serinus Biosciences in?
Serinus Biosciences was in Y Combinator's Summer 2022 batch (S22).
Is Serinus Biosciences still active?
Y Combinator lists Serinus Biosciences as active.
Where is Serinus Biosciences based?
Serinus Biosciences lists New York City, NY, USA; New York, NY, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.